FDA Warning Letter — PREMIER NUTRA PHARMA Inc.

Case 640210 — FEI 3017303868

The FDA took a Warning Letter action against PREMIER NUTRA PHARMA Inc. on Dec 9, 2022 (Carlsbad, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
PREMIER NUTRA PHARMA Inc.
Date
Dec 9, 2022
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Carlsbad, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.